0001666071-21-000011.txt : 20210212 0001666071-21-000011.hdr.sgml : 20210212 20210212183623 ACCESSION NUMBER: 0001666071-21-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210210 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laube Lynne Marie CENTRAL INDEX KEY: 0001730687 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 21630823 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_161317295842273.xml FORM 4 X0306 4 2021-02-10 0 0001666071 Cardlytics, Inc. CDLX 0001730687 Laube Lynne Marie C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 1 1 0 0 Chief Executive Officer Common Stock 2021-02-10 4 M 0 2139 8.32 A 299145 D Common Stock 2021-02-10 4 S 0 126 150.19 D 299019 D Common Stock 2021-02-10 4 S 0 498 151.05 D 298521 D Common Stock 2021-02-10 4 S 0 500 151.80 D 298021 D Common Stock 2021-02-10 4 S 0 315 153.08 D 297706 D Common Stock 2021-02-10 4 S 0 100 154.16 D 297606 D Common Stock 2021-02-10 4 S 0 500 155.72 D 297106 D Common Stock 2021-02-10 4 S 0 100 157.98 D 297006 D Common Stock 2021-02-11 4 M 0 2139 8.32 A 299145 D Common Stock 2021-02-11 4 S 0 100 149.41 D 299045 D Common Stock 2021-02-11 4 S 0 215 150.89 D 298830 D Common Stock 2021-02-11 4 S 0 610 151.78 D 298220 D Common Stock 2021-02-11 4 S 0 400 152.74 D 297820 D Common Stock 2021-02-11 4 S 0 100 153.71 D 297720 D Common Stock 2021-02-11 4 S 0 400 154.46 D 297320 D Common Stock 2021-02-11 4 S 0 314 154.98 D 297006 D Common Stock 14565 I See Footnote Common Stock 14565 I See Footnote Employee Stock Option (Right to Buy) 8.32 2021-02-10 4 M 0 2139 0 D 2023-07-18 Common Stock 2139.0 16119 D Employee Stock Option (Right to Buy) 8.32 2021-02-11 4 M 0 2139 0 D 2023-07-18 Common Stock 2139.0 13980 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11) and (12) to this Form 4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $150.92 to $151.16, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $151.31 to $152.26, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $152.62 to $153.57, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $154.15 to $154.22, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $155.19 to $156.03, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $150.70 to $151.06, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $151.09 to $152.08, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $152.29 to $153.00, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $153.83 to $154.70, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $154.84 to $155.22, inclusive. The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright. The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright. Fully vested. /s/ Kirk Somers, Attorney-in-Fact 2021-02-12